Leukocyte depletion during cardiac surgery with extracorporeal circulation in high risk patients

Inflamm Res. 2008 Dec;57(12):577-85. doi: 10.1007/s00011-008-8031-8.

Abstract

Background: Cardiopulmonary bypass is associated with systemic inflammation that may contribute to increased perioperative mortality. Depletion of circulating leukocytes may reduce the inflammatory response. We studied the effect of a leukocyte depleting filter on leukocyte activation during cardiopulmonary bypass in high risk patients.

Methods: Fifty patients undergoing coronary artery bypass grafting with a preoperative high risk were randomly placed in an arterial line leukocyte filter group (n = 25) with a leukocyte depleting filter. Blood sampling took place from the arterial line to analyze polymorphnuclear elastase and myeloperoxidase at six time points, including: A) before the induction of anesthesia, B) before the induction of the cardiopulmonary bypass C) 1 min after the release of the aorta clamp, D) the end of the operation, E) 1 h postoperative, and F) 24 h postoperative.

Results: Levels of polymorphonuclear elastase, (PMNE), and myeloperoxidase (MPO) were found to be higher after the release of the aortic cross clamp in the leukocyte filter group; these levels remained elevated until 24 hours after surgery and were high in comparison to preoperative baseline levels. The differences in PMNE between both groups at time points C and D (p < 0.005) and E (p < 0.05) were statistically significant. The serum levels of the S-100B and neuron specific enolase (NSE) were found to be elevated between time points C and E in both groups without statistical significance. The in-hospital mortality was 16% (4 patients) in leukocyte filter group and 4% in control group (1 patient).

Conclusions: Interestingly, the activation of neutrophils was more pronounced in the LF group. The use of a leucocyte depleting filter was not advantageous for this patient cohort for clinical or biomedical endpoints.

Publication types

  • Evaluation Study

MeSH terms

  • Aged
  • Aged, 80 and over
  • Cardiac Surgical Procedures*
  • Extracorporeal Circulation* / adverse effects
  • Extracorporeal Circulation* / instrumentation
  • Extracorporeal Circulation* / methods
  • Humans
  • Inflammation / etiology*
  • Inflammation / immunology
  • Intraoperative Period
  • Leukocyte Count
  • Leukocyte Reduction Procedures / methods*
  • Leukocytes*
  • Male
  • Peroxidase / metabolism
  • Risk Factors

Substances

  • Peroxidase